

Publisher: Karger
E-ISSN: 1660-3818|36|2|141-143
ISSN: 1660-3796
Source: Transfusion Medicine and Hemotherapy, Vol.36, Iss.2, 2009-03, pp. : 141-143
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Argatroban Therapy in Patients with Coronary Artery Disease and Heparin-Induced Thrombocytopenia
Cardiology, Vol. 109, Iss. 3, 2007-08 ,pp. :








Heparin-Induced Thrombocytopenia: Frequency and Pathogenesis
Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. :